A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects
NCT ID: NCT02066922
Last Updated: 2015-06-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2014-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT01561560
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT01634659
A Prospective Study of Two Daily Disposable Contact Lenses
NCT01636986
Clinical Evaluation of Daily Disposable Contact Lenses
NCT02097030
Performance Assessment of a Modified Daily Disposable Contact Lens
NCT03762668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DAILIES TOTAL1
Delefilcon A contact lens randomly assigned to one eye, with narafilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.
Delefilcon A contact lens
Commercially available silicone hydrogel contact lens
Narafilcon A contact lens
Commercially available silicone hydrogel contact lens
Spectacles
Incremental prescription worn over contact lenses if needed to provide acceptable vision
TRUEYE
Narafilcon A contact lens randomly assigned to one eye, with delefilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.
Delefilcon A contact lens
Commercially available silicone hydrogel contact lens
Narafilcon A contact lens
Commercially available silicone hydrogel contact lens
Spectacles
Incremental prescription worn over contact lenses if needed to provide acceptable vision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delefilcon A contact lens
Commercially available silicone hydrogel contact lens
Narafilcon A contact lens
Commercially available silicone hydrogel contact lens
Spectacles
Incremental prescription worn over contact lenses if needed to provide acceptable vision
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Higher degree of myopia in both eyes, i.e. habitual contact lens power between -10.00 diopters (D) and -17.00D;
* Best corrected distance visual acuity greater than or equal to 20/30 in each eye (measured with either spectacle refraction or habitual contact lenses plus over refraction);
* Manifest astigmatism less than or equal to -1.00D;
* Soft contact lens wear in both eyes at least 5 days per week and at least 8 hours per day;
Exclusion Criteria
* Eye injury or surgery within twelve weeks immediately prior to enrollment;
* Any ocular condition that contraindicates contact lens wear;
* History of herpetic keratitis;
* Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including any use of topical ocular medications that would require instillation during contact lens wear, except for approved lubricating drops;
* Clinical significant dry eye not responding to treatment;
* Previous corneal or refractive surgery or irregular cornea;
* Requires reading glasses;
* Participation in a clinical trial (including contact lens or contact lens care product) within the previous 30 days;
* Wears habitual lenses in an extended wear modality (routinely sleeps in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joachim Nick, Dipl. Ing.
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-12-057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.